Use and outcomes of adjuvant chemotherapy in older women with breast cancer

Journal of Clinical Oncology

Volumn 24, Issue 18, 2006, Pages 2750-2756

  Giordano, Sharon H ^a   Duan, Zhigang ^a   Kuo, Yong Fang ^a   Hortobagyi, Gabriel N ^a   Goodwin, James S ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; GOSERELIN; INTERFERON; LEUPRORELIN; MESNA; METHOTREXATE; MITOXANTRONE;

AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CALCULATION; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA BASE; DRUG USE; ETHNIC DIFFERENCE; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SCORING SYSTEM; ADJUVANT CHEMOTHERAPY; BREAST TUMOR; CANCER REGISTRY; LYMPH NODE METASTASIS; MORTALITY; PATHOLOGY; SURVIVAL;

AGED; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; LYMPHATIC METASTASIS; PROPORTIONAL HAZARDS MODELS; SEER PROGRAM; SURVIVAL ANALYSIS;

EID: 33745528525     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.02.3028     Document Type: Article

References (29)

1. Polychemotherapy for early breast cancer: An overview of the randomised trials: Early Breast Cancer Trialists' Collaborative Group. Lancet 352:930-942, 1998
2. Muss HB, Woolf S, Berry D, et al: Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA 293:1073-1081, 2005
3. Thuerlimann B: International consensus meeting on the treatment of primary breast cancer 2001, St. Gallen, Switzerland. Breast Cancer 8:294-297, 2001
4. Clinical Practice Guidelines in Oncology: Breast Cancer (version 2.2006), National Comprehensive Cancer Network, 2006 http://www.nccn.org/ professionals/physician_gls/PDF/breast.pdf
5. Giordano SH, Hortobagyi GN, Kau SW, et al: Breast cancer treatment guidelines in older women. J Clin Oncol 23:783-791, 2005
6. Mandelblatt JS, Hadley J, Kerner JF, et al: Patterns of breast carcinoma treatment in older women: Patient preference and clinical and physical influences. Cancer 89:561-573, 2000
7. DeMichele A, Putt M, Zhang Y, et al: Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma: Evidence from a tertiary care cohort of chemotherapy-eligible patients. Cancer 97:2150-2159, 2003
8. Du X, Goodwin JS: Increase of chemotherapy use in older women with breast carcinoma from 1991 to 1996. Cancer 92:730-737, 2001
9. Du XL, Osborne C, Goodwin JS: Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer. J Clin Oncol 20:463-4642, 2002
10. Health Care Financing Administration: HCFA Common Procedure Coding System (HCPCS): National Level II Medicare Codes. Los Angeles, CA, Practice Management Information Corp, 1994
11. American Medical Association: Physicians' Current Procedural Terminology: CPT 94. Chicago, IL, American Medical Association, 1993
12. Du X, Goodwin JS: Patterns of use of chemotherapy for breast cancer in older women: Findings from Medicare claims data. J Clin Oncol 19:1455-1461, 2001
13. Charlson ME, Pompei P, Ales KL, et al: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40:373-383, 1987
14. Romano PS, Roos LL, Jollis JG: Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectives. J Clin Epidemiol 46:1075-1079, 1081-1090, 1993
15. National Cancer Institute: SEER-Medicare: Calculation of Comorbidity Weights. http://health-services.cancer.gov/seermedicare/program/comorbidity.html
16. Stokes M, Davis C, Koch G: Categorical Data Using the SAS System. Cary, NC, SAS Institute Inc, 2000
17. Grambasch PM, Therneau T: Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81:515-526, 1994
18. Elkin EB, Hurria A, Mitra N, et al: Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: Assessing outcome in a population-based observational cohort. J Clin Oncol 24:10.1200/JCO.2005.03. 6053
19. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet 365:1687-1717, 2005
20. Berry D, Cirrincione C, Henderson IC, et al: Effects of improvements in chemotherapy on disease-free and overall survival of estrogen-receptor negative, node positive breast cancer: 20-year experience of the CALGB and U.S. Breast Intergroup. Breast Cancer Res Treat 88:29-41, 2004
21. Mariotto A, Feuer EJ, Harlan LC, et al: Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999. J Natl Cancer Inst 94:1626-1634, 2002
22. NIH Consensus Conference: Treatment of early-stage breast cancer. JAMA 265:391-395, 1991
23. Glick JH, Gelber RD, Goldhirsch A, et al: Meeting highlights: Adjuvant therapy for primary breast cancer. J Natl Cancer Inst 84:1479-1485, 1992
24. Wen SW, Hernandez R, Naylor CD: Pitfalls in nonrandomized outcomes studies: The case of incidental appendectomy with open cholecystectomy. JAMA 274:1687-1691, 1995
25. Schrag D, Rifas-Shiman S, Saltz L, et al: Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer. J Clin Oncol 20:3999-4005, 2002
26. Iwashyna TJ, Lamont EB: Effectiveness of adjuvant fluorouracil in clinical practice: A population-based cohort study of elderly patients with stage III colon cancer. J Clin Oncol 20:3992-3998, 2002
27. Lyman GH, Dale DC, Crawford J: Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: A nationwide study of community practices. J Clin Oncol 21:4524-4531, 2003
28. Nattinger AB, McAuliffe TL, Schapira MM: Generalizability of the surveillance, epidemiology, and end results registry population: Factors relevant to epidemiologic and health care research. J Clin Epidemiol 50:939-945, 1997
29. Arias E, Smith B: Deaths: Preliminary data for 2001. Natl Vital Stat Rep 51:1-44, 2003